文献速递中药与中成药合理使用

利用组学方法解读中医药

Exploiting omic-based approaches to decipher Traditional Chinese Medicine.
PubMed 文献 · J Ethnopharmacol · 2024-10-15

本文综述了组学技术在中医药现代化中的应用,涵盖成分分析、质量控制、生物标志物发现、靶点鉴定及治疗优化。文章通过检索PubMed等数据库的相关文献,指出组学策略有助于中药质量控制、细胞靶点识别、新药发现及作用机制理解,并讨论了精准中医药治疗的未来前景。

要点

  • 组学技术可助力中药质量控制与作用机制解析。
  • 组学策略支持生物标志物发现和药物靶点鉴定。
  • 实现中医药全球化需发展稳健的组学策略与数据基础设施。

核心结论

  • 要全面将中医药融入现代医学,需进一步发展稳健的组学策略,包括个性化医学、先进计算能力和安全数据基础设施。

研究设计与样本

  • 综述检索了PubMed、ClinicalTrials、Google Scholar和Web of Science数据库,聚焦中医药、组学策略、精准医学、生物标志物、质量控制和分子机制相关文章。

主要发现

  • 组学策略有助于中药质量控制、细胞靶点识别、新药发现及作用机制理解。
  • 中医药和中药材在全球日益受到关注,部分由组学等技术推动其现代化。

临床怎么用

  • 可应用组学技术进行中药质量控制、生物标志物发现和靶点鉴定。
  • 利用组学策略优化中医药治疗并推动精准中医药发展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese Medicine (TCM), an ancient health system, faces significant research challenges due to the complexity of its active components and targets, as well as a historical lack of detailed annotation. However, recent advances in omics technologies have begun to unravel these complexities, providing a more informed and nuanced understanding of TCM's therapeutic potential in contemporary healthcare. AIM OF THE REVIEW: This review summarizes the application of omics technologies in TCM modernization, emphasizing components analysis, quality control, biomarker discovery, target identification, and treatment optimization. In addition, future perspectives on using omics for precision TCM treatment are also discussed. MATERIALS AND METHODS: We have explored several databases (including PubMed, ClinicalTrials, Google Scholar, and Web of Science) to review related articles, focusing on Traditional Chinese Medicine, Omics Strategy, Precision Medicine, Biomarkers, Quality Control, and Molecular Mechanisms. Paper selection criteria involved English grammar, publication date, high citations, and broad applicability, exclusion criteria included low credibility, non-English publications, and those full-text inaccessible ones. RESULTS: TCM and the popularity of Chinese herbal medicines (CHMs) are gaining increasing attention worldwide. This is driven, in part, by a large number of technologies, especially omics strategy, which are aiding the modernization of TCM. They contribute to the quality control of CHMs, the identification of cellular targets, discovery of new drugs and, most importantly, the understanding of their mechanisms of action. CONCLUSION: To fully integrate TCM into modern medicine, further development of robust omics strategies is essential. This vision includes personalized medicine, backed by advanced computational power and secure data infrastructure, to facilitate global acceptance and seamless integration of TCM practices.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Li L, Guan Y, Du Y, et al. Exploiting omic-based approaches to decipher Traditional Chinese Medicine. J Ethnopharmacol. 2024. PMID: 39413937. doi:10.1016/j.jep.2024.118936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。